Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure
Pascal de Groote, MDa,
Alain Millaire, MD, PhDa,
Claude Foucher-Hossein, MD*,
Olivier Nugue, MDa,
Xavier Marchandise, MD, PhD*,
G.érard Ducloux, MDa and
Jean-Marc Lablanche, MD, FACCa
a Service de Cardiologie C, Hôpital Cardiologique, Lille, France
* the Service Central de Médecine Nucléaire et Imagerie Fonctionnelle, Hôpital Roger Salengro, Lille, France
View larger version (29K):
[in a new window]
|
Figure 1 Relationship between RVEF and percent of maximal predicted VO2 (top) and between RVEF and SPAP (bottom). The 35 patients with nonsignificant tricuspid regurgitation were excluded. Figure shows individual values, regression line and 95% prediction intervals.
|
|
View larger version (11K):
[in a new window]
|
Figure 2 Event-free survival curve from cardiovascular mortality and urgent transplantation (UNOS1) for the whole population.
|
|
View larger version (20K):
[in a new window]
|
Figure 3 Event-free survival curves from cardiac mortality and urgent transplantation (UNOS1) in the two subgroups of patients divided according to the median value of the RVEF (top), of the LVEF (middle) and of the percent of maximal predicted VO2 (bottom).
|
|
View larger version (13K):
[in a new window]
|
Figure 4 Receiver operating characteristic curve of the RVEF in determining event-free survival from cardiovascular mortality and urgent transplantation at 1 year.
|
|
View larger version (19K):
[in a new window]
|
Figure 5 Event-free survival curves from cardiovascular mortality and urgent transplantation in the three subgroups of patients divided according to the RVEF <25%, RVEF between 25 and 35% and RVEF  35%.
|
|
|
